Deliberations by the Central Social Insurance Medical Council on the Medical Device for Treating Male Stress Urinary Incontinence, “セルーション セルセラピーキット SUI”
ADRセラピューティクス株式会社 (a subsidiary of the filing company)
Medical device for treating male stress urinary incontinence, “セルーション セルセラピーキット SUI”
Related procedures
Deliberations on insurance coverage by the Central Social Insurance Medical Council
Central Social Insurance Medical Council; Ministry of Health, Labour and Welfare
The impact of this matter on the performance of the Group is currently under review. The company will promptly disclose any matters that should be made public.
Insurance coverage is expected to be finalized following the results of the deliberations and the prescribed procedures, including notices and notifications issued by the Ministry of Health, Labour and Welfare. Formal insurance coverage is scheduled to begin on 1 December 2026, but the effective date will be finalized through notices and notifications issued by the Ministry of Health, Labour and Welfare. After the product is marketed, a post-marketing surveillance study (PMS) covering all cases will be conducted.
The company will promptly disclose the results of the deliberations once they become available.
| Item | Details |
|---|---|
| Event name | Deliberations by the Central Social Insurance Medical Council on the Medical Device for Treating Male Stress Urinary Incontinence, “セルーション セルセラピーキット SUI” |
| Date of occurrence | 16 September 2026 (the date deliberated at the plenary meeting of the Central Social Insurance Medical Council) |
| Subject Entity | ADRセラピューティクス株式会社 (a subsidiary of the filing company) |
| Target Locations / Products | Medical device for treating male stress urinary incontinence, “セルーション セルセラピーキット SUI” |
| Impact on Earnings Forecast | The impact of this matter on the performance of the Group is currently under review. The company will promptly disclose any matters that should be made public. |
| Type of litigation or proceeding | Deliberations on insurance coverage by the Central Social Insurance Medical Council |
| Court or authority | Central Social Insurance Medical Council; Ministry of Health, Labour and Welfare |
| Outlook | Insurance coverage is expected to be finalized following the results of the deliberations and the prescribed procedures, including notices and notifications issued by the Ministry of Health, Labour and Welfare. Formal insurance coverage is scheduled to begin on 1 December 2026, but the effective date will be finalized through notices and notifications issued by the Ministry of Health, Labour and Welfare. After the product is marketed, a post-marketing surveillance study (PMS) covering all cases will be conducted. |
| Planned follow-up disclosure | The company will promptly disclose the results of the deliberations once they become available. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.At the plenary meeting of the Central Social Insurance Medical Council held on 16 September 2026, materials concerning insurance coverage and other matters that included this product were deliberated. Formal insurance coverage is expected to be finalized following the results of the deliberations and the procedures including notices and notifications issued by the Ministry of Health, Labour and Welfare.